Moderna's Flu Vaccine Moves Closer to FDA Approval

The FDA advisory committee recommended Moderna's flu vaccine for approval. Moderna CEO Stéphane Bancel tells Romaine Bostick and Katie Greifeld he is cautiously optimistic that the agency will follow the guidance. A final decision by the FDA is expected by August 5 which is just in time for the next flu season. He speaks on "Bloomberg The Close."